186 related articles for article (PubMed ID: 21234716)
1. Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in multi transfused Indian thalassemia patients.
Merchant RH; Shirodkar A; Ahmed J
Indian J Pediatr; 2011 Jun; 78(6):679-83. PubMed ID: 21234716
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of growth and puberty failure with respect to growth hormone and gonadotropins secretion in beta-thalassemia major.
Moayeri H; Oloomi Z
Arch Iran Med; 2006 Oct; 9(4):329-34. PubMed ID: 17061604
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of growth and endocrine disorders in Malaysian children with transfusion-dependent thalassaemia.
Tan KA; Lum SH; Yahya A; Krishnan S; Jalaludin MY; Lee WS
Singapore Med J; 2019 Jun; 60(6):303-308. PubMed ID: 30556093
[TBL] [Abstract][Full Text] [Related]
4. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
Shalitin S; Carmi D; Weintrob N; Phillip M; Miskin H; Kornreich L; Zilber R; Yaniv I; Tamary H
Eur J Haematol; 2005 Feb; 74(2):93-100. PubMed ID: 15654898
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major.
Najafipour F; Aliasgarzadeh A; Aghamohamadzadeh N; Bahrami A; Mobasri M; Niafar M; Khoshbaten M
Ann Saudi Med; 2008; 28(5):361-6. PubMed ID: 18779644
[TBL] [Abstract][Full Text] [Related]
6. Endocrine complications in patients with Thalassaemia Major.
Toumba M; Sergis A; Kanaris C; Skordis N
Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
[TBL] [Abstract][Full Text] [Related]
7. Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC.
Soliman AT; Yassin MA; De Sanctis V
Acta Biomed; 2018 Feb; 89(2-S):27-32. PubMed ID: 29451226
[TBL] [Abstract][Full Text] [Related]
8. Hypogonadism in male thalassemia major patients: pathophysiology, diagnosis and treatment.
De Sanctis V; Soliman AT; Yassin MA; Di Maio S; Daar S; Elsedfy H; Soliman N; Kattamis C
Acta Biomed; 2018 Feb; 89(2-S):6-15. PubMed ID: 29451224
[TBL] [Abstract][Full Text] [Related]
9. [Effect of hematologic treatment on the growth and puberty of children with thalassemia major].
Pomarède R; Girot R; Constant S; Rappaport R
Arch Fr Pediatr; 1984 Apr; 41(4):255-9. PubMed ID: 6477042
[TBL] [Abstract][Full Text] [Related]
10. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
11. Iron burden and endocrine complications in transfusion-dependent thalassemia patients In Sarawak, Malaysia: a retrospective study.
Chow LC; Lee BS; Tang SO; Loh EW; Ng SC; Tan XY; Ahmad Noordin MN; Ong GB; Chew LC
Med J Malaysia; 2024 May; 79(3):281-287. PubMed ID: 38817060
[TBL] [Abstract][Full Text] [Related]
12. Management of thalassemias: growth and development, hormone substitution, vitamin supplementation, and vaccination.
Kattamis CA; Kattamis AC
Semin Hematol; 1995 Oct; 32(4):269-79. PubMed ID: 8560284
[No Abstract] [Full Text] [Related]
13. Growth and puberty in thalassemia major.
Raiola G; Galati MC; De Sanctis V; Caruso Nicoletti M; Pintor C; De Simone M; Arcuri VM; Anastasi S
J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():259-66. PubMed ID: 12729401
[TBL] [Abstract][Full Text] [Related]
14. Failure of puberty in Egyptian beta thalassemic patients: experience in north east region - Dakahlia province.
Abdelrazik N; Ghanem H
Hematology; 2007 Oct; 12(5):449-56. PubMed ID: 17852439
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease.
Fung EB; Harmatz PR; Lee PD; Milet M; Bellevue R; Jeng MR; Kalinyak KA; Hudes M; Bhatia S; Vichinsky EP;
Br J Haematol; 2006 Nov; 135(4):574-82. PubMed ID: 17054676
[TBL] [Abstract][Full Text] [Related]
16. Growth and endocrine function in thalassemia major in childhood and adolescence.
Delvecchio M; Cavallo L
J Endocrinol Invest; 2010 Jan; 33(1):61-8. PubMed ID: 20203539
[TBL] [Abstract][Full Text] [Related]
17. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
Wang C; Tso SC; Todd D
J Clin Endocrinol Metab; 1989 Mar; 68(3):511-6. PubMed ID: 2493034
[TBL] [Abstract][Full Text] [Related]
18. Effect of iron overload on endocrinopathies in patients with beta-thalassaemia major and intermedia.
Kurtoglu AU; Kurtoglu E; Temizkan AK
Endokrynol Pol; 2012; 63(4):260-3. PubMed ID: 22933160
[TBL] [Abstract][Full Text] [Related]
19. Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major.
Farmaki K; Tzoumari I; Pappa C; Chouliaras G; Berdoukas V
Br J Haematol; 2010 Feb; 148(3):466-75. PubMed ID: 19912219
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of endocrine disorders and their associated factors in transfusion-dependent thalassemia patients: a historical cohort study in Southern Iran.
Bordbar M; Bozorgi H; Saki F; Haghpanah S; Karimi M; Bazrafshan A; Zekavat OR
J Endocrinol Invest; 2019 Dec; 42(12):1467-1476. PubMed ID: 31228105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
